Reduced expression of CA7 was significantly correlated with poor differentiation, positive lymph node metastasis, advanced TNM stage and unfavorable clinical outcome not only in the training cohort but also in the validation set. The gene discussed is CA7; the disease is metastatic malignant neoplasm in the lymph nodes.